The United States and our G7 partners are mobilizing to defeat COVID-19 through historic funding, donations and capacity building, demonstrating how democracies can provide for our people and the world.
This week in Cornwall, the United States and G7 + leaders announced more than a billion safe and effective COVID-19 vaccines to accelerate global coverage. The announcement means that since 2020, the G7 + has pledged to fund and deliver around 2.3 billion vaccines to the world. The United States provides nearly half of that support and is the world’s largest donor of COVID-19 vaccines. This total of $ 2.3 billion includes support for expanding local production capacity around the world to add more than one billion doses to the global vaccine supply by the end of 2022.
Anticipated funding and sharing: The G7 + countries have already pledged to finance and share more than a billion doses.
- Since the creation of COVAX, the G7 + countries have already committed more than 1 billion doses via COVAX to date in direct funding and in doses.
- This includes more than 330 million US dose equivalents in COVAX funding and at least 80 million US vaccines donated to the world from oversupply.
Investments in local vaccine production: The G7 + investment in local vaccine production capacity will support at least 1 billion doses of vaccine by the end of 2022.
- Through partnerships like the Quad Vaccine Partnership of the United States, India, Japan and Australia, the G7 + is committed to developing local production for at least 1 billion doses safe and effective COVID-19 vaccines in 2021 and 2022.
- The U.S. International Development Finance Corporation (DFC) is leading this effort and is also working with counterpart development finance institutions, including the International Finance Corporation, Proparco, and DEG, to support vaccine manufacturing in Africa – for the ‘Africa.
This week: The G7 + has agreed to provide more than a billion additional doses from the summer of 2021.
- This week in Cornwall, G7 + leaders agreed to provide at least 1 billion doses safe and effective COVID-19 vaccines to accelerate global immunization coverage, especially for the poorest countries.
- The United States has announced its commitment to buy and contribute to Gavi or support COVAX 500 million doses Pfizer BioNTech COVID-19 vaccine, which will begin delivery in August 2021, as part of about half of the G7 + ‘s overall commitment. The United States will allocate these doses to 92 low and lower middle income countries around the world. It is the largest purchase and donation of vaccines in the world by a single country.
The United States calls on countries to donate extra doses of safe and effective vaccines, strengthen vaccine preparedness, and work with private sector partners to immunize the world. In addition to supporting the G7 + commitment on vaccines, the United States will continue to share doses from our national supply as they become available.
# # #